Plasma-condition RiLac and CTx alone showed a modest but significant reduction of the metabolic activity in MiaPaca (Figure 2b) but not PaTuS (Figure 2c) pancreatic cancer cells. This evidence concerns the gene CYP27A1 and familial pancreatic carcinoma.